{
  "scan_date": "2026-02-06",
  "scan_time": "2026-02-06T10:06:38.716443",
  "summary": {
    "fda_new": 17,
    "ema_new": 14,
    "mfds_new": 7,
    "total_new": 38,
    "hot_issues": 15
  },
  "fda_new": [
    {
      "source": "fda",
      "drug_name": "PRIMAQUINE PHOSPHATE",
      "generic_name": "PRIMAQUINE PHOSPHATE",
      "approval_date": "1952-01-23",
      "application_number": "NDA008316",
      "indication": "",
      "sponsor": "SANOFI AVENTIS US",
      "is_breakthrough": false,
      "is_accelerated": false,
      "is_orphan": false,
      "is_prime": false,
      "hot_issue_type": "none",
      "hot_issue_score": 0,
      "hot_issue_reasons": [],
      "matched_existing": true,
      "existing_approvals": [
        "mfds"
      ]
    },
    {
      "source": "fda",
      "drug_name": "ARSENIC TRIOXIDE",
      "generic_name": "ARSENIC TRIOXIDE",
      "approval_date": "2021-10-15",
      "application_number": "ANDA214011",
      "indication": "",
      "sponsor": "EUGIA PHARMA",
      "is_breakthrough": false,
      "is_accelerated": false,
      "is_orphan": false,
      "is_prime": false,
      "hot_issue_type": "global_concurrent",
      "hot_issue_score": 25,
      "hot_issue_reasons": [
        "FDA+EMA 동시 승인"
      ],
      "matched_existing": true,
      "existing_approvals": [
        "ema",
        "mfds"
      ]
    },
    {
      "source": "fda",
      "drug_name": "LIVDELZI",
      "generic_name": "SELADELPAR LYSINE",
      "approval_date": "2024-08-14",
      "application_number": "NDA217899",
      "indication": "",
      "sponsor": "GILEAD SCIENCES INC",
      "is_breakthrough": false,
      "is_accelerated": false,
      "is_orphan": false,
      "is_prime": false,
      "hot_issue_type": "global_concurrent",
      "hot_issue_score": 25,
      "hot_issue_reasons": [
        "FDA+EMA 동시 승인"
      ],
      "matched_existing": true,
      "existing_approvals": [
        "fda",
        "ema"
      ]
    },
    {
      "source": "fda",
      "drug_name": "ZYPREXA",
      "generic_name": "OLANZAPINE",
      "approval_date": "1996-09-30",
      "application_number": "NDA020592",
      "indication": "Atypical Antipsychotic [EPC]",
      "sponsor": "CHEPLAPHARM",
      "is_breakthrough": false,
      "is_accelerated": false,
      "is_orphan": false,
      "is_prime": false,
      "hot_issue_type": "global_concurrent",
      "hot_issue_score": 25,
      "hot_issue_reasons": [
        "FDA+EMA 동시 승인"
      ],
      "matched_existing": true,
      "existing_approvals": [
        "ema",
        "mfds"
      ]
    },
    {
      "source": "fda",
      "drug_name": "ZYPREXA ZYDIS",
      "generic_name": "OLANZAPINE",
      "approval_date": "2000-04-06",
      "application_number": "NDA021086",
      "indication": "Atypical Antipsychotic [EPC]",
      "sponsor": "CHEPLAPHARM",
      "is_breakthrough": false,
      "is_accelerated": false,
      "is_orphan": false,
      "is_prime": false,
      "hot_issue_type": "global_concurrent",
      "hot_issue_score": 25,
      "hot_issue_reasons": [
        "FDA+EMA 동시 승인"
      ],
      "matched_existing": true,
      "existing_approvals": [
        "ema",
        "mfds"
      ]
    },
    {
      "source": "fda",
      "drug_name": "ZYPREXA RELPREVV",
      "generic_name": "OLANZAPINE PAMOATE",
      "approval_date": "2009-12-11",
      "application_number": "NDA022173",
      "indication": "",
      "sponsor": "CHEPLAPHARM",
      "is_breakthrough": false,
      "is_accelerated": false,
      "is_orphan": false,
      "is_prime": false,
      "hot_issue_type": "none",
      "hot_issue_score": 0,
      "hot_issue_reasons": [],
      "matched_existing": false,
      "existing_approvals": []
    },
    {
      "source": "fda",
      "drug_name": "CONCERTA",
      "generic_name": "METHYLPHENIDATE HYDROCHLORIDE",
      "approval_date": "2000-08-01",
      "application_number": "NDA021121",
      "indication": "",
      "sponsor": "JANSSEN PHARMS",
      "is_breakthrough": false,
      "is_accelerated": false,
      "is_orphan": false,
      "is_prime": false,
      "hot_issue_type": "global_concurrent",
      "hot_issue_score": 25,
      "hot_issue_reasons": [
        "FDA+EMA 동시 승인"
      ],
      "matched_existing": true,
      "existing_approvals": [
        "fda",
        "fda",
        "fda",
        "fda",
        "ema",
        "mfds"
      ]
    },
    {
      "source": "fda",
      "drug_name": "LYBALVI",
      "generic_name": "OLANZAPINE AND SAMIDORPHAN L-MALATE",
      "approval_date": "2021-05-28",
      "application_number": "NDA213378",
      "indication": "Atypical Antipsychotic [EPC]",
      "sponsor": "ALKERMES INC",
      "is_breakthrough": false,
      "is_accelerated": false,
      "is_orphan": false,
      "is_prime": false,
      "hot_issue_type": "none",
      "hot_issue_score": 0,
      "hot_issue_reasons": [],
      "matched_existing": false,
      "existing_approvals": []
    },
    {
      "source": "fda",
      "drug_name": "AMOXICILLIN AND CLAVULANATE POTASSIUM",
      "generic_name": "AMOXICILLIN AND CLAVULANATE POTASSIUM",
      "approval_date": "2007-11-09",
      "application_number": "ANDA065373",
      "indication": "",
      "sponsor": "HIKMA PHARMS",
      "is_breakthrough": false,
      "is_accelerated": false,
      "is_orphan": false,
      "is_prime": false,
      "hot_issue_type": "none",
      "hot_issue_score": 0,
      "hot_issue_reasons": [],
      "matched_existing": false,
      "existing_approvals": []
    },
    {
      "source": "fda",
      "drug_name": "NORLIQVA",
      "generic_name": "AMLODIPINE",
      "approval_date": "2022-02-24",
      "application_number": "NDA214439",
      "indication": "Dihydropyridine Calcium Channel Blocker [EPC], Calcium Channel Blocker [EPC]",
      "sponsor": "CMP DEV LLC",
      "is_breakthrough": false,
      "is_accelerated": false,
      "is_orphan": false,
      "is_prime": false,
      "hot_issue_type": "global_concurrent",
      "hot_issue_score": 25,
      "hot_issue_reasons": [
        "FDA+EMA 동시 승인"
      ],
      "matched_existing": true,
      "existing_approvals": [
        "fda",
        "ema"
      ]
    },
    {
      "source": "fda",
      "drug_name": "DAPTOMYCIN",
      "generic_name": "DAPTOMYCIN",
      "approval_date": "2021-06-29",
      "application_number": "ANDA213786",
      "indication": "Lipopeptide Antibacterial [EPC]",
      "sponsor": "MEITHEAL",
      "is_breakthrough": false,
      "is_accelerated": false,
      "is_orphan": false,
      "is_prime": false,
      "hot_issue_type": "global_concurrent",
      "hot_issue_score": 25,
      "hot_issue_reasons": [
        "FDA+EMA 동시 승인"
      ],
      "matched_existing": true,
      "existing_approvals": [
        "fda",
        "ema",
        "mfds"
      ]
    },
    {
      "source": "fda",
      "drug_name": "PUR-WASH",
      "generic_name": "WATER",
      "approval_date": "2011-09-01",
      "application_number": "NDA022305",
      "indication": "",
      "sponsor": "NIAGARA PHARMS",
      "is_breakthrough": false,
      "is_accelerated": false,
      "is_orphan": false,
      "is_prime": false,
      "hot_issue_type": "none",
      "hot_issue_score": 0,
      "hot_issue_reasons": [],
      "matched_existing": true,
      "existing_approvals": [
        "fda",
        "fda",
        "fda"
      ]
    },
    {
      "source": "fda",
      "drug_name": "RYBELSUS",
      "generic_name": "ORAL SEMAGLUTIDE",
      "approval_date": "2019-09-20",
      "application_number": "NDA213051",
      "indication": "GLP-1 Receptor Agonist [EPC]",
      "sponsor": "NOVO",
      "is_breakthrough": false,
      "is_accelerated": false,
      "is_orphan": false,
      "is_prime": false,
      "hot_issue_type": "none",
      "hot_issue_score": 0,
      "hot_issue_reasons": [],
      "matched_existing": false,
      "existing_approvals": []
    },
    {
      "source": "fda",
      "drug_name": "VENLAFAXINE HYDROCHLORIDE",
      "generic_name": "VENLAFAXINE HYDROCHLORIDE",
      "approval_date": "2018-11-23",
      "application_number": "ANDA201272",
      "indication": "",
      "sponsor": "MEDICAP LABS",
      "is_breakthrough": false,
      "is_accelerated": false,
      "is_orphan": false,
      "is_prime": false,
      "hot_issue_type": "none",
      "hot_issue_score": 0,
      "hot_issue_reasons": [],
      "matched_existing": true,
      "existing_approvals": [
        "fda",
        "mfds"
      ]
    },
    {
      "source": "fda",
      "drug_name": "ZYPREXA INTRAMUSCULAR",
      "generic_name": "OLANZAPINE",
      "approval_date": "2004-03-29",
      "application_number": "NDA021253",
      "indication": "Atypical Antipsychotic [EPC]",
      "sponsor": "CHEPLAPHARM",
      "is_breakthrough": false,
      "is_accelerated": false,
      "is_orphan": false,
      "is_prime": false,
      "hot_issue_type": "global_concurrent",
      "hot_issue_score": 25,
      "hot_issue_reasons": [
        "FDA+EMA 동시 승인"
      ],
      "matched_existing": true,
      "existing_approvals": [
        "ema",
        "mfds"
      ]
    },
    {
      "source": "fda",
      "drug_name": "ENBREL",
      "generic_name": "ETANERCEPT",
      "approval_date": "1998-11-02",
      "application_number": "BLA103795",
      "indication": "Tumor Necrosis Factor Blocker [EPC]",
      "sponsor": "IMMUNEX",
      "is_breakthrough": false,
      "is_accelerated": false,
      "is_orphan": false,
      "is_prime": false,
      "hot_issue_type": "global_concurrent",
      "hot_issue_score": 35,
      "hot_issue_reasons": [
        "FDA+EMA 동시 승인",
        "고관심 적응증 (tumor)"
      ],
      "matched_existing": true,
      "existing_approvals": [
        "fda",
        "ema",
        "mfds"
      ]
    },
    {
      "source": "fda",
      "drug_name": "CETIRIZINE HCL",
      "generic_name": "CETIRIZINE HCL",
      "approval_date": "2009-07-23",
      "application_number": "NDA022429",
      "indication": "",
      "sponsor": "BIONPHARMA",
      "is_breakthrough": false,
      "is_accelerated": false,
      "is_orphan": false,
      "is_prime": false,
      "hot_issue_type": "none",
      "hot_issue_score": 0,
      "hot_issue_reasons": [],
      "matched_existing": true,
      "existing_approvals": [
        "fda"
      ]
    }
  ],
  "ema_new": [
    {
      "source": "ema",
      "drug_name": "Eltrombopag Viatris",
      "generic_name": "eltrombopag",
      "approval_date": "2024-12-12",
      "application_number": "",
      "indication": "Purpura, Thrombocytopenic, Idiopathic",
      "sponsor": "Viatris Limited",
      "is_breakthrough": false,
      "is_accelerated": false,
      "is_orphan": false,
      "is_prime": false,
      "hot_issue_type": "none",
      "hot_issue_score": 0,
      "hot_issue_reasons": [],
      "matched_existing": true,
      "existing_approvals": [
        "ema"
      ]
    },
    {
      "source": "ema",
      "drug_name": "Exjade",
      "generic_name": "deferasirox",
      "approval_date": "2006-08-28",
      "application_number": "",
      "indication": "beta-Thalassemia;Iron Overload",
      "sponsor": "Novartis Europharm Limited",
      "is_breakthrough": false,
      "is_accelerated": false,
      "is_orphan": false,
      "is_prime": false,
      "hot_issue_type": "none",
      "hot_issue_score": 0,
      "hot_issue_reasons": [],
      "matched_existing": true,
      "existing_approvals": [
        "ema",
        "mfds"
      ]
    },
    {
      "source": "ema",
      "drug_name": "Dasatinib Accord Healthcare",
      "generic_name": "dasatinib",
      "approval_date": "2024-07-26",
      "application_number": "",
      "indication": "Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive",
      "sponsor": "Accord Healthcare S.L.U.",
      "is_breakthrough": false,
      "is_accelerated": false,
      "is_orphan": false,
      "is_prime": false,
      "hot_issue_type": "global_concurrent",
      "hot_issue_score": 35,
      "hot_issue_reasons": [
        "EMA+FDA 동시 승인",
        "고관심 적응증 (lymphoma)"
      ],
      "matched_existing": true,
      "existing_approvals": [
        "fda",
        "ema",
        "mfds"
      ]
    },
    {
      "source": "ema",
      "drug_name": "Vanflyta",
      "generic_name": "quizartinib",
      "approval_date": "2023-11-06",
      "application_number": "",
      "indication": "Leukemia, Myeloid",
      "sponsor": "Daiichi Sankyo Europe GmbH",
      "is_breakthrough": false,
      "is_accelerated": false,
      "is_orphan": false,
      "is_prime": false,
      "hot_issue_type": "high_interest",
      "hot_issue_score": 10,
      "hot_issue_reasons": [
        "고관심 적응증 (leukemia)"
      ],
      "matched_existing": true,
      "existing_approvals": [
        "ema"
      ]
    },
    {
      "source": "ema",
      "drug_name": "Yuflyma",
      "generic_name": "adalimumab",
      "approval_date": "2021-02-11",
      "application_number": "",
      "indication": "Arthritis, Rheumatoid;Arthritis, Psoriatic;Psoriasis;Spondylitis, Ankylosing;Uveitis;Hidradenitis Suppurativa;Colitis, Ulcerative;Crohn Disease;Arthritis, Juvenile Rheumatoid",
      "sponsor": "Celltrion Healthcare Hungary Kft.",
      "is_breakthrough": false,
      "is_accelerated": false,
      "is_orphan": false,
      "is_prime": false,
      "hot_issue_type": "global_concurrent",
      "hot_issue_score": 25,
      "hot_issue_reasons": [
        "EMA+FDA 동시 승인"
      ],
      "matched_existing": true,
      "existing_approvals": [
        "fda",
        "ema",
        "mfds"
      ]
    },
    {
      "source": "ema",
      "drug_name": "DuoTrav",
      "generic_name": "travoprost;timolol",
      "approval_date": "2006-04-23",
      "application_number": "",
      "indication": "Glaucoma, Open-Angle;Ocular Hypertension",
      "sponsor": "Novartis Europharm Limited",
      "is_breakthrough": false,
      "is_accelerated": false,
      "is_orphan": false,
      "is_prime": false,
      "hot_issue_type": "none",
      "hot_issue_score": 0,
      "hot_issue_reasons": [],
      "matched_existing": true,
      "existing_approvals": [
        "ema"
      ]
    },
    {
      "source": "ema",
      "drug_name": "Sugammadex Amomed",
      "generic_name": "sugammadex",
      "approval_date": "2023-01-10",
      "application_number": "",
      "indication": "Neuromuscular Blockade",
      "sponsor": "AOP Orphan Pharmaceuticals GmbH",
      "is_breakthrough": false,
      "is_accelerated": false,
      "is_orphan": false,
      "is_prime": false,
      "hot_issue_type": "none",
      "hot_issue_score": 0,
      "hot_issue_reasons": [],
      "matched_existing": true,
      "existing_approvals": [
        "ema"
      ]
    },
    {
      "source": "ema",
      "drug_name": "Gilenya",
      "generic_name": "fingolimod",
      "approval_date": "2011-03-17",
      "application_number": "",
      "indication": "Multiple Sclerosis",
      "sponsor": "Novartis Europharm Limited",
      "is_breakthrough": false,
      "is_accelerated": false,
      "is_orphan": false,
      "is_prime": false,
      "hot_issue_type": "none",
      "hot_issue_score": 0,
      "hot_issue_reasons": [],
      "matched_existing": true,
      "existing_approvals": [
        "ema"
      ]
    },
    {
      "source": "ema",
      "drug_name": "Uzpruvo",
      "generic_name": "ustekinumab",
      "approval_date": "2024-01-05",
      "application_number": "",
      "indication": "Psoriasis;Arthritis, Psoriatic;Crohn Disease;Colitis, Ulcerative",
      "sponsor": "Stada Arzneimittel AG",
      "is_breakthrough": false,
      "is_accelerated": false,
      "is_orphan": false,
      "is_prime": false,
      "hot_issue_type": "global_concurrent",
      "hot_issue_score": 25,
      "hot_issue_reasons": [
        "EMA+FDA 동시 승인"
      ],
      "matched_existing": true,
      "existing_approvals": [
        "fda",
        "fda",
        "fda",
        "ema",
        "mfds"
      ]
    },
    {
      "source": "ema",
      "drug_name": "Trazimera",
      "generic_name": "trastuzumab",
      "approval_date": "2018-07-26",
      "application_number": "",
      "indication": "Stomach Neoplasms;Breast Neoplasms",
      "sponsor": "Pfizer Europe MA EEIG",
      "is_breakthrough": false,
      "is_accelerated": false,
      "is_orphan": false,
      "is_prime": false,
      "hot_issue_type": "global_concurrent",
      "hot_issue_score": 25,
      "hot_issue_reasons": [
        "EMA+FDA 동시 승인"
      ],
      "matched_existing": true,
      "existing_approvals": [
        "fda",
        "fda",
        "fda",
        "ema",
        "mfds"
      ]
    },
    {
      "source": "ema",
      "drug_name": "GalliaPharm",
      "generic_name": "gallium (68Ga) chloride;germanium (68Ge) chloride",
      "approval_date": "2024-08-01",
      "application_number": "",
      "indication": "Radionuclide Imaging",
      "sponsor": "Eckert & Ziegler Radiopharma GmbH",
      "is_breakthrough": false,
      "is_accelerated": false,
      "is_orphan": false,
      "is_prime": false,
      "hot_issue_type": "none",
      "hot_issue_score": 0,
      "hot_issue_reasons": [],
      "matched_existing": true,
      "existing_approvals": [
        "ema"
      ]
    },
    {
      "source": "ema",
      "drug_name": "Vizamyl",
      "generic_name": "flutemetamol (18F)",
      "approval_date": "2014-08-22",
      "application_number": "",
      "indication": "Radionuclide Imaging;Alzheimer Disease",
      "sponsor": "GE Healthcare AS",
      "is_breakthrough": false,
      "is_accelerated": false,
      "is_orphan": false,
      "is_prime": false,
      "hot_issue_type": "high_interest",
      "hot_issue_score": 10,
      "hot_issue_reasons": [
        "고관심 적응증 (alzheimer)"
      ],
      "matched_existing": true,
      "existing_approvals": [
        "ema",
        "mfds"
      ]
    },
    {
      "source": "ema",
      "drug_name": "Rezurock",
      "generic_name": "Belumosudil",
      "approval_date": "2026-01-30",
      "application_number": "",
      "indication": "Graft vs Host Disease",
      "sponsor": "Sanofi Winthrop Industrie",
      "is_breakthrough": false,
      "is_accelerated": false,
      "is_orphan": true,
      "is_prime": false,
      "hot_issue_type": "global_concurrent",
      "hot_issue_score": 50,
      "hot_issue_reasons": [
        "EMA+FDA 동시 승인",
        "희귀의약품",
        "EMA Conditional Approval"
      ],
      "matched_existing": true,
      "existing_approvals": [
        "fda",
        "ema"
      ]
    },
    {
      "source": "ema",
      "drug_name": "Trulicity",
      "generic_name": "dulaglutide",
      "approval_date": "2014-11-21",
      "application_number": "",
      "indication": "Diabetes Mellitus, Type 2",
      "sponsor": "Eli Lilly Nederland B.V.",
      "is_breakthrough": false,
      "is_accelerated": false,
      "is_orphan": false,
      "is_prime": false,
      "hot_issue_type": "global_concurrent",
      "hot_issue_score": 35,
      "hot_issue_reasons": [
        "EMA+FDA 동시 승인",
        "고관심 적응증 (diabetes)"
      ],
      "matched_existing": true,
      "existing_approvals": [
        "fda",
        "ema",
        "mfds"
      ]
    }
  ],
  "mfds_new": [
    {
      "source": "mfds",
      "drug_name": "씨투케어정50밀리그램(프란루카스트수화물)",
      "generic_name": "Pranlukast Hydrate",
      "approval_date": "2026-01-30",
      "application_number": "202600277",
      "indication": "",
      "sponsor": "(주)바이넥스",
      "is_breakthrough": false,
      "is_accelerated": false,
      "is_orphan": false,
      "is_prime": false,
      "hot_issue_type": "none",
      "hot_issue_score": 0,
      "hot_issue_reasons": [],
      "matched_existing": true,
      "existing_approvals": [
        "mfds"
      ]
    },
    {
      "source": "mfds",
      "drug_name": "락토락시럽(락툴로오스농축액)",
      "generic_name": "Lactulose Concentrate Solution",
      "approval_date": "2026-01-30",
      "application_number": "202600282",
      "indication": "",
      "sponsor": "(주)마더스제약",
      "is_breakthrough": false,
      "is_accelerated": false,
      "is_orphan": false,
      "is_prime": false,
      "hot_issue_type": "none",
      "hot_issue_score": 0,
      "hot_issue_reasons": [],
      "matched_existing": true,
      "existing_approvals": [
        "mfds"
      ]
    },
    {
      "source": "mfds",
      "drug_name": "쿨드림롱정(독시라민숙신산염)",
      "generic_name": "Doxylamine Succinate",
      "approval_date": "2026-01-30",
      "application_number": "202600284",
      "indication": "",
      "sponsor": "(주)녹십자",
      "is_breakthrough": false,
      "is_accelerated": false,
      "is_orphan": false,
      "is_prime": false,
      "hot_issue_type": "none",
      "hot_issue_score": 0,
      "hot_issue_reasons": [],
      "matched_existing": true,
      "existing_approvals": [
        "mfds"
      ]
    },
    {
      "source": "mfds",
      "drug_name": "텔미트리플정80/5/25밀리그램(텔미사르탄,암로디핀,클로르탈리돈)",
      "generic_name": "Amlodipine Besylate/Chlorthalidone/Telmisartan",
      "approval_date": "2026-01-30",
      "application_number": "202600285",
      "indication": "",
      "sponsor": "(주)녹십자",
      "is_breakthrough": false,
      "is_accelerated": false,
      "is_orphan": false,
      "is_prime": false,
      "hot_issue_type": "none",
      "hot_issue_score": 0,
      "hot_issue_reasons": [],
      "matched_existing": true,
      "existing_approvals": [
        "mfds"
      ]
    },
    {
      "source": "mfds",
      "drug_name": "텔미트리플정80/5/12.5밀리그램(텔미사르탄,암로디핀,클로르탈리돈)",
      "generic_name": "Amlodipine Besylate/Chlorthalidone/Telmisartan",
      "approval_date": "2026-01-30",
      "application_number": "202600286",
      "indication": "",
      "sponsor": "(주)녹십자",
      "is_breakthrough": false,
      "is_accelerated": false,
      "is_orphan": false,
      "is_prime": false,
      "hot_issue_type": "none",
      "hot_issue_score": 0,
      "hot_issue_reasons": [],
      "matched_existing": true,
      "existing_approvals": [
        "mfds"
      ]
    },
    {
      "source": "mfds",
      "drug_name": "텔미트리플정40/5/12.5밀리그램(텔미사르탄,암로디핀,클로르탈리돈)",
      "generic_name": "Amlodipine Besylate/Chlorthalidone/Telmisartan",
      "approval_date": "2026-01-30",
      "application_number": "202600287",
      "indication": "",
      "sponsor": "(주)녹십자",
      "is_breakthrough": false,
      "is_accelerated": false,
      "is_orphan": false,
      "is_prime": false,
      "hot_issue_type": "none",
      "hot_issue_score": 0,
      "hot_issue_reasons": [],
      "matched_existing": true,
      "existing_approvals": [
        "mfds"
      ]
    },
    {
      "source": "mfds",
      "drug_name": "토마토정10밀리그램(토파시티닙시트르산염)",
      "generic_name": "Tofacitinib Citrate",
      "approval_date": "2026-02-02",
      "application_number": "202600292",
      "indication": "",
      "sponsor": "(주)한국피엠지제약",
      "is_breakthrough": false,
      "is_accelerated": false,
      "is_orphan": false,
      "is_prime": false,
      "hot_issue_type": "none",
      "hot_issue_score": 0,
      "hot_issue_reasons": [],
      "matched_existing": true,
      "existing_approvals": [
        "mfds"
      ]
    }
  ],
  "hot_issues": [
    {
      "source": "ema",
      "drug_name": "Rezurock",
      "generic_name": "Belumosudil",
      "approval_date": "2026-01-30",
      "application_number": "",
      "indication": "Graft vs Host Disease",
      "sponsor": "Sanofi Winthrop Industrie",
      "is_breakthrough": false,
      "is_accelerated": false,
      "is_orphan": true,
      "is_prime": false,
      "hot_issue_type": "global_concurrent",
      "hot_issue_score": 50,
      "hot_issue_reasons": [
        "EMA+FDA 동시 승인",
        "희귀의약품",
        "EMA Conditional Approval"
      ],
      "matched_existing": true,
      "existing_approvals": [
        "fda",
        "ema"
      ]
    },
    {
      "source": "fda",
      "drug_name": "ENBREL",
      "generic_name": "ETANERCEPT",
      "approval_date": "1998-11-02",
      "application_number": "BLA103795",
      "indication": "Tumor Necrosis Factor Blocker [EPC]",
      "sponsor": "IMMUNEX",
      "is_breakthrough": false,
      "is_accelerated": false,
      "is_orphan": false,
      "is_prime": false,
      "hot_issue_type": "global_concurrent",
      "hot_issue_score": 35,
      "hot_issue_reasons": [
        "FDA+EMA 동시 승인",
        "고관심 적응증 (tumor)"
      ],
      "matched_existing": true,
      "existing_approvals": [
        "fda",
        "ema",
        "mfds"
      ]
    },
    {
      "source": "ema",
      "drug_name": "Dasatinib Accord Healthcare",
      "generic_name": "dasatinib",
      "approval_date": "2024-07-26",
      "application_number": "",
      "indication": "Precursor Cell Lymphoblastic Leukemia-Lymphoma;Leukemia, Myelogenous, Chronic, BCR-ABL Positive",
      "sponsor": "Accord Healthcare S.L.U.",
      "is_breakthrough": false,
      "is_accelerated": false,
      "is_orphan": false,
      "is_prime": false,
      "hot_issue_type": "global_concurrent",
      "hot_issue_score": 35,
      "hot_issue_reasons": [
        "EMA+FDA 동시 승인",
        "고관심 적응증 (lymphoma)"
      ],
      "matched_existing": true,
      "existing_approvals": [
        "fda",
        "ema",
        "mfds"
      ]
    },
    {
      "source": "ema",
      "drug_name": "Trulicity",
      "generic_name": "dulaglutide",
      "approval_date": "2014-11-21",
      "application_number": "",
      "indication": "Diabetes Mellitus, Type 2",
      "sponsor": "Eli Lilly Nederland B.V.",
      "is_breakthrough": false,
      "is_accelerated": false,
      "is_orphan": false,
      "is_prime": false,
      "hot_issue_type": "global_concurrent",
      "hot_issue_score": 35,
      "hot_issue_reasons": [
        "EMA+FDA 동시 승인",
        "고관심 적응증 (diabetes)"
      ],
      "matched_existing": true,
      "existing_approvals": [
        "fda",
        "ema",
        "mfds"
      ]
    },
    {
      "source": "fda",
      "drug_name": "ARSENIC TRIOXIDE",
      "generic_name": "ARSENIC TRIOXIDE",
      "approval_date": "2021-10-15",
      "application_number": "ANDA214011",
      "indication": "",
      "sponsor": "EUGIA PHARMA",
      "is_breakthrough": false,
      "is_accelerated": false,
      "is_orphan": false,
      "is_prime": false,
      "hot_issue_type": "global_concurrent",
      "hot_issue_score": 25,
      "hot_issue_reasons": [
        "FDA+EMA 동시 승인"
      ],
      "matched_existing": true,
      "existing_approvals": [
        "ema",
        "mfds"
      ]
    },
    {
      "source": "fda",
      "drug_name": "LIVDELZI",
      "generic_name": "SELADELPAR LYSINE",
      "approval_date": "2024-08-14",
      "application_number": "NDA217899",
      "indication": "",
      "sponsor": "GILEAD SCIENCES INC",
      "is_breakthrough": false,
      "is_accelerated": false,
      "is_orphan": false,
      "is_prime": false,
      "hot_issue_type": "global_concurrent",
      "hot_issue_score": 25,
      "hot_issue_reasons": [
        "FDA+EMA 동시 승인"
      ],
      "matched_existing": true,
      "existing_approvals": [
        "fda",
        "ema"
      ]
    },
    {
      "source": "fda",
      "drug_name": "ZYPREXA",
      "generic_name": "OLANZAPINE",
      "approval_date": "1996-09-30",
      "application_number": "NDA020592",
      "indication": "Atypical Antipsychotic [EPC]",
      "sponsor": "CHEPLAPHARM",
      "is_breakthrough": false,
      "is_accelerated": false,
      "is_orphan": false,
      "is_prime": false,
      "hot_issue_type": "global_concurrent",
      "hot_issue_score": 25,
      "hot_issue_reasons": [
        "FDA+EMA 동시 승인"
      ],
      "matched_existing": true,
      "existing_approvals": [
        "ema",
        "mfds"
      ]
    },
    {
      "source": "fda",
      "drug_name": "ZYPREXA ZYDIS",
      "generic_name": "OLANZAPINE",
      "approval_date": "2000-04-06",
      "application_number": "NDA021086",
      "indication": "Atypical Antipsychotic [EPC]",
      "sponsor": "CHEPLAPHARM",
      "is_breakthrough": false,
      "is_accelerated": false,
      "is_orphan": false,
      "is_prime": false,
      "hot_issue_type": "global_concurrent",
      "hot_issue_score": 25,
      "hot_issue_reasons": [
        "FDA+EMA 동시 승인"
      ],
      "matched_existing": true,
      "existing_approvals": [
        "ema",
        "mfds"
      ]
    },
    {
      "source": "fda",
      "drug_name": "CONCERTA",
      "generic_name": "METHYLPHENIDATE HYDROCHLORIDE",
      "approval_date": "2000-08-01",
      "application_number": "NDA021121",
      "indication": "",
      "sponsor": "JANSSEN PHARMS",
      "is_breakthrough": false,
      "is_accelerated": false,
      "is_orphan": false,
      "is_prime": false,
      "hot_issue_type": "global_concurrent",
      "hot_issue_score": 25,
      "hot_issue_reasons": [
        "FDA+EMA 동시 승인"
      ],
      "matched_existing": true,
      "existing_approvals": [
        "fda",
        "fda",
        "fda",
        "fda",
        "ema",
        "mfds"
      ]
    },
    {
      "source": "fda",
      "drug_name": "NORLIQVA",
      "generic_name": "AMLODIPINE",
      "approval_date": "2022-02-24",
      "application_number": "NDA214439",
      "indication": "Dihydropyridine Calcium Channel Blocker [EPC], Calcium Channel Blocker [EPC]",
      "sponsor": "CMP DEV LLC",
      "is_breakthrough": false,
      "is_accelerated": false,
      "is_orphan": false,
      "is_prime": false,
      "hot_issue_type": "global_concurrent",
      "hot_issue_score": 25,
      "hot_issue_reasons": [
        "FDA+EMA 동시 승인"
      ],
      "matched_existing": true,
      "existing_approvals": [
        "fda",
        "ema"
      ]
    },
    {
      "source": "fda",
      "drug_name": "DAPTOMYCIN",
      "generic_name": "DAPTOMYCIN",
      "approval_date": "2021-06-29",
      "application_number": "ANDA213786",
      "indication": "Lipopeptide Antibacterial [EPC]",
      "sponsor": "MEITHEAL",
      "is_breakthrough": false,
      "is_accelerated": false,
      "is_orphan": false,
      "is_prime": false,
      "hot_issue_type": "global_concurrent",
      "hot_issue_score": 25,
      "hot_issue_reasons": [
        "FDA+EMA 동시 승인"
      ],
      "matched_existing": true,
      "existing_approvals": [
        "fda",
        "ema",
        "mfds"
      ]
    },
    {
      "source": "fda",
      "drug_name": "ZYPREXA INTRAMUSCULAR",
      "generic_name": "OLANZAPINE",
      "approval_date": "2004-03-29",
      "application_number": "NDA021253",
      "indication": "Atypical Antipsychotic [EPC]",
      "sponsor": "CHEPLAPHARM",
      "is_breakthrough": false,
      "is_accelerated": false,
      "is_orphan": false,
      "is_prime": false,
      "hot_issue_type": "global_concurrent",
      "hot_issue_score": 25,
      "hot_issue_reasons": [
        "FDA+EMA 동시 승인"
      ],
      "matched_existing": true,
      "existing_approvals": [
        "ema",
        "mfds"
      ]
    },
    {
      "source": "ema",
      "drug_name": "Yuflyma",
      "generic_name": "adalimumab",
      "approval_date": "2021-02-11",
      "application_number": "",
      "indication": "Arthritis, Rheumatoid;Arthritis, Psoriatic;Psoriasis;Spondylitis, Ankylosing;Uveitis;Hidradenitis Suppurativa;Colitis, Ulcerative;Crohn Disease;Arthritis, Juvenile Rheumatoid",
      "sponsor": "Celltrion Healthcare Hungary Kft.",
      "is_breakthrough": false,
      "is_accelerated": false,
      "is_orphan": false,
      "is_prime": false,
      "hot_issue_type": "global_concurrent",
      "hot_issue_score": 25,
      "hot_issue_reasons": [
        "EMA+FDA 동시 승인"
      ],
      "matched_existing": true,
      "existing_approvals": [
        "fda",
        "ema",
        "mfds"
      ]
    },
    {
      "source": "ema",
      "drug_name": "Uzpruvo",
      "generic_name": "ustekinumab",
      "approval_date": "2024-01-05",
      "application_number": "",
      "indication": "Psoriasis;Arthritis, Psoriatic;Crohn Disease;Colitis, Ulcerative",
      "sponsor": "Stada Arzneimittel AG",
      "is_breakthrough": false,
      "is_accelerated": false,
      "is_orphan": false,
      "is_prime": false,
      "hot_issue_type": "global_concurrent",
      "hot_issue_score": 25,
      "hot_issue_reasons": [
        "EMA+FDA 동시 승인"
      ],
      "matched_existing": true,
      "existing_approvals": [
        "fda",
        "fda",
        "fda",
        "ema",
        "mfds"
      ]
    },
    {
      "source": "ema",
      "drug_name": "Trazimera",
      "generic_name": "trastuzumab",
      "approval_date": "2018-07-26",
      "application_number": "",
      "indication": "Stomach Neoplasms;Breast Neoplasms",
      "sponsor": "Pfizer Europe MA EEIG",
      "is_breakthrough": false,
      "is_accelerated": false,
      "is_orphan": false,
      "is_prime": false,
      "hot_issue_type": "global_concurrent",
      "hot_issue_score": 25,
      "hot_issue_reasons": [
        "EMA+FDA 동시 승인"
      ],
      "matched_existing": true,
      "existing_approvals": [
        "fda",
        "fda",
        "fda",
        "ema",
        "mfds"
      ]
    }
  ],
  "errors": []
}